Compass Pathways Announces Pricing of Underwritten Offering

Contributed by: Business Wire

Tags

Mental Health

Health

Health Technology

Clinical Trials

Pharmaceutical

Biotechnology

mental health

More Like This

Compass Pathways Announces Pricing of $150 Million Public Offering

Compass Pathways Launches Proposed $150.0 Million Public Offering

Compass Pathways Announces Exercise of $200 Million in Outstanding Warrants

Compass Pathways to Participate in Four Investor Conferences in September

Compass Pathways to Participate in Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 in Boston, MA

Compass Pathways to Participate in Stifel 2025 Healthcare Conference

Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit

Compass Pathways to Participate in Two Investor Conferences in December